NCKAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.484600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.176600E-01
Normal-vs-Stage2
2.325800E-01
Normal-vs-Stage3
8.699600E-01
Normal-vs-Stage4
1.183850E-01
Stage1-vs-Stage2
7.099800E-01
Stage1-vs-Stage3
4.383000E-01
Stage1-vs-Stage4
1.025790E-01
Stage2-vs-Stage3
2.593200E-01
Stage2-vs-Stage4
6.631600E-02
Stage3-vs-Stage4
7.458100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.531600E-01
Normal-vs-AfricanAmerican
2.301200E-01
Normal-vs-Asian
4.984800E-01
Caucasian-vs-AfricanAmerican
2.668200E-01
Caucasian-vs-Asian
7.280000E-01
AfricanAmerican-vs-Asian
3.726200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.522200E-01
Normal-vs-Female
2.568200E-01
Male-vs-Female
6.833200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.901800E-01
Normal-vs-Age(41-60Yrs)
1.225230E-01
Normal-vs-Age(61-80Yrs)
3.244000E-01
Normal-vs-Age(81-100Yrs)
5.040000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.380400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.659000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.774400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.509710E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.853700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.793200E-01
Normal-vs-Daily Drinker
6.415600E-01
Normal-vs-Weekly Drinker
4.201400E-01
Normal-vs-Occasional Drinker
9.822400E-02
Normal-vs-Social Drinker
3.211800E-01
Non Drinker-vs-Daily Drinker
5.758600E-01
Non Drinker-vs-Weekly Drinker
7.569400E-01
Non Drinker-vs-Occasional Drinker
1.238100E-02
Non Drinker-vs-Social Drinker
3.398200E-01
Daily Drinker-vs-Weekly Drinker
4.438400E-01
Daily Drinker-vs-Occasional Drinker
5.458500E-03
Daily Drinker-vs-Social Drinker
1.792830E-01
Weekly Drinker-vs-Occasional Drinker
7.110400E-02
Weekly Drinker-vs-Social Drinker
5.851200E-01
Occasional Drinker-vs-Social Drinker
2.258400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.021780E-01
Normal-vs-Grade 2
1.148070E-02
Normal-vs-Grade 3
1.594420E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.196400E-02
Grade 1-vs-Grade 3
1.420090E-02
Grade 1-vs-Grade 4
1.021780E-01
Grade 2-vs-Grade 3
2.350400E-01
Grade 2-vs-Grade 4
1.148070E-02
Grade 3-vs-Grade 4
1.594420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.873600E-01
Normal-vs-NonDiabetic
2.411800E-01
Diabetic-vs-NonDiabetic
2.386000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.505000E-01
Normal-vs-NoPancreatitis
2.819600E-01
Pancreatitis-vs-NoPancreatitis
5.724600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.461800E-01
Normal-vs-N1
2.130600E-01
N0-vs-N1
4.960600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.381700E-02
Normal-vs-TP53-NonMutant
3.458600E-01
TP53-Mutant-vs-TP53-NonMutant
9.597600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
